Pulse Biosciences Inc Revenue Growth Rates (PLSE), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Pulse Biosciences Inc   (NASDAQ: PLSE)
 

PLSE's Revenue Growth by Quarter and Year

Pulse Biosciences Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/PLSE/growth
https://api.csimarket.com/api/v1/companies/PLSE/fundamentals
https://api.csimarket.com/api/v1/companies/PLSE/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
PLSE Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 0.40
2nd Quarter June 0.43
1st Quarter March 0.40
FY 1.23

PLSEs Annual Revenue
Pulse Biosciences Inc 's Revenue in the fiscal year 2025 $ 0.35 millions
Pulse Biosciences Inc 's Revenue in the fiscal year 2024 $ 0.00 millions
Pulse Biosciences Inc 's Revenue in the fiscal year 2023 $ 0.00 millions
Pulse Biosciences Inc 's Revenue in the fiscal year 2022 $ 0.70 millions
Pulse Biosciences Inc 's Revenue in the fiscal year 2021 $ 1.42 millions




PLSE Revenue third quarter 2026 Y/Y Growth Comment
Pulse Biosciences Inc achieved in the third quarter 2026, above Company average Revenue surge of 338.89% year on year, to $ 0.40 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue growth. While Pulse Biosciences Inc ' s Revenue doubling of 338.89% ranks overall at the positon no. 969 in the third quarter 2026.


PLSE Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 338.89 %
2nd Quarter June -
1st Quarter March -
FY   -

Financial Statements
Pulse Biosciences Inc 's third quarter 2026 Revenue $ 0.40 millions PLSE's Income Statement
Pulse Biosciences Inc 's third quarter 2025 Revenue $ 0.09 millions Quarterly PLSE's Income Statement


PLSE Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -8.14 %
2nd Quarter June 7.5 %
1st Quarter March 53.85 %
FY (Year on Year)   -


Back to PLSE Growth rate Comparisons >> Back to PLSE Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #145
Overall #969

Revenue Y/Y Growth Statistics
High Average Low
933.33 % 40.28 % -100 %
(Sep 30 2016)   (Jun 30 2017)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #145
Overall #969
Revenue Y/Y Growth Statistics
High Average Low
933.33 % 40.28 % -100 %
(Sep 30 2016)   (Jun 30 2017)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Pulse Biosciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
933.33 % 40.28 % -100 %
(Sep 30 2016)  


PLSE's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Pulse Biosciences Inc disclosed drop in Revenue from the second quarter by -8.14% to $ 0.40 millions, from $ 0.43 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Pulse Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 969.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #145
Overall #969
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #145
Overall #969
Revenue Q/Q Growth Statistics
High Average Low
933.33 % 40.28 % -100 %
(Sep 30 2016)  


PLSE's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Pulse Biosciences Inc disclosed drop in Revenue from the second quarter by -8.14% to $ 0.40 millions, from $ 0.43 millions achived in the previous reporting period.

Within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Pulse Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 969.


Pulse Biosciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 1.19
Y / Y Revenue Growth (TTM) -
Year on Year Revenue Growth Overall Ranking #
Seqeuential Revenue Change (TTM) -
Seq. Revenue Growth (TTM) Overall Ranking #


Cumulative Revenue growth Comment
Pulse Biosciences Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 338.89% year on year, to $ 1 millions if the fiscal year would have ended in Jun 30 2026.
Pulse Biosciences Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Pulse Biosciences Inc realized the fastest Revenue growth, in Medical Equipment & Supplies industry.

Pulse Biosciences Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
Pulse Biosciences Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 338.89% year on year, to $ 1 millions if the fiscal year would have ended in Jun 30 2026.
Pulse Biosciences Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Pulse Biosciences Inc realized the fastest Revenue growth, in Medical Equipment & Supplies industry.

Pulse Biosciences Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PLSE's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Brightspring Health Services Inc 588.43%$ 588.428 millions
Bio Green Med Solution Inc 460.49%$ 460.494 millions
Xencor Inc454.88%$ 454.884 millions
Tonix Pharmaceuticals Holding Corp 423.83%$ 423.830 millions
Nakamoto Inc 396.90%$ 396.897 millions
EBR Systems, Inc.385.65%$ 385.647 millions
Solana Company382.07%$ 382.066 millions
Pulse Biosciences Inc 359.30%$ 359.302 millions
Ensysce Biosciences Inc 342.43%$ 342.428 millions
Nexalin Technology Inc 331.43%$ 331.434 millions
Agios Pharmaceuticals Inc 330.01%$ 330.008 millions
Insmed Inc330.00%$ 330.000 millions
Monte Rosa Therapeutics Inc 325.80%$ 325.799 millions
Liquidia Corporation314.60%$ 314.596 millions
Stablecoin Development Corporation310.75%$ 310.749 millions
Renovorx Inc 300.75%$ 300.752 millions
Aligos Therapeutics Inc 281.92%$ 281.916 millions
Clene Inc 273.33%$ 273.333 millions
Recursion Pharmaceuticals Inc 258.49%$ 258.493 millions
Nuvation Bio Inc 251.98%$ 251.977 millions
Seastar Medical Holding Corp246.99%$ 246.995 millions
Prime Medicine Inc 243.92%$ 243.918 millions
Urogen Pharma Ltd 227.16%$ 227.161 millions
Dianthus Therapeutics Inc 205.56%$ 205.556 millions
Bridgebio Pharma Inc 192.60%$ 192.602 millions
Bicycle Therapeutics Plc190.24%$ 190.242 millions
Gossamer Bio Inc 189.09%$ 189.085 millions
Alpha Cognition Inc.173.75%$ 173.751 millions


About Pulse Biosciences Inc Revenue Growth Rates (PLSE), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Pulse Biosciences Inc (CIK 1625101).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-035267
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Pulse Biosciences Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.